Published in Eur J Clin Pharmacol on January 01, 1993
Factors influencing the effectiveness of glucagon for preventing hypoglycemia. J Diabetes Sci Technol (2010) 1.18
Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol Endocrinol Metab (2014) 0.81
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline. J Int Med Res (1978) 1.16
Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat. Brain Res (1974) 1.14
Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients. Diabetes Care (1989) 1.05
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? Arch Neurol (1982) 1.01
Long-term treatment with mianserin: a clinical study with plasma levels. Adv Biochem Psychopharmacol (1982) 0.95
Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results. J Neurol Neurosurg Psychiatry (1975) 0.93
Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management. Diabetes Metab Rev (1994) 0.92
PrP genotype in Sarda breed sheep and its relevance to scrapie. Brief report. Arch Virol (2001) 0.90
Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes. Eur Neurol (1975) 0.89
Neurochemical investigation of an endogenous model of the "hyperkinetic syndrome" in a hybrid dog. Life Sci (1979) 0.87
Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 0.86
Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective. Clin Pharmacokinet (1989) 0.86
Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release. Diabete Metab (1989) 0.81
Mechanism of action of piribedil on noradrenergic neurons in rat brain. Biochem Pharmacol (1978) 0.81
Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain. Eur J Pharmacol (1974) 0.81
Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects. Diabete Metab (1988) 0.80
Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry (1999) 0.80
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.80
Acetylcholinesterase activity in ventricular and cisternal CSF of dogs: effect of chlorpromazine. J Neurosci Res (1978) 0.79
Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa. Eur Neuropsychopharmacol (2010) 0.79
Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain. Eur J Pharmacol (1978) 0.79
Metaraminol and monoamineoxidase activity in the rat heart. Res Commun Chem Pathol Pharmacol (1971) 0.78
Effects of flunitrazepam on cognitive functions. Psychopharmacology (Berl) (1989) 0.78
Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents. Eur J Clin Pharmacol (1989) 0.78
Effects of amphetamine, electrical stimulation and stress on endogenous MOPEG-SO4 levels in rat brain. Pharmacol Res Commun (1978) 0.78
Correlation between desipramine levels and (-)-noradrenaline uptake and chronotropic effect in isolated atria of rats. Br J Pharmacol (1973) 0.78
Urinary excretion of 3-methoxy-4-hydroxyphenylglycol sulfate in rats after intraventricular injection of 6-OHDA. Brain Res (1974) 0.78
Pituitary reserve after repeated administrations of releasing hormones in young and in elderly men: reproducibility on different days. J Endocrinol Invest (1992) 0.77
Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study. J Clin Psychopharmacol (1997) 0.77
Pharmacokinetics of chlordesmethyldiazepam after single-dose oral administration in humans. Eur J Drug Metab Pharmacokinet (1987) 0.77
Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine. Metabolism (1993) 0.77
Ultrasonographic evaluation of gallbladder volume and contractility in diabetic patients of different ages. Diabete Metab (1992) 0.76
Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. J Endocrinol Invest (1991) 0.76
Interaction of metergoline with striatal dopamine system. Life Sci (1978) 0.76
Determination of 5-chloro-7-iodo-8-quinolinol (clioquinol) in plasma and tissues of hamsters by high-performance liquid chromatography and electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'. Int Clin Psychopharmacol (2000) 0.75
Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat. Br J Pharmacol (1979) 0.75
The bioequivalence and therapeutic efficacy. Clin Ther (2004) 0.75
HLA phenotype and secondary failure to oral hypoglycaemic agents. Diabetologia (1987) 0.75
[Methergoline in the prevention and interruption of puerperal lactation: a multicenter clinico-biological study]. Farmaco Prat (1982) 0.75
Secondary failure of oral hypoglycaemic agents in lean patients with type 2 diabetes mellitus: insulin sensitivity, insulin response to different stimuli, and the role of cyclic-AMP. Diabete Metab (1992) 0.75
Improvement of glucose tolerance by minimal doses of glipizide in obese subjects with different degrees of glucose intolerance. Horm Metab Res Suppl (1992) 0.75
Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease. Diabete Metab (1993) 0.75
[Neuromuscular diseases at the local Central-South Medical Unit of Bolzano: orthopedic aspects]. Chir Organi Mov (1988) 0.75
Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM). Eur J Clin Pharmacol (1991) 0.75
Relationships between tricyclic antidepressant concentrations, 1-3H-noradrenaline uptake and chronotropic effect in isolated rat atria. Eur J Pharmacol (1974) 0.75
[Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss]. Minerva Med (1982) 0.75
[Non-insulin-dependent diabetes mellitus. Genetic and metabolic risk factors in the development of micro- and macro-angiopathic complications]. Minerva Endocrinol (1986) 0.75
Hydroxyhaloperidol and clinical outcome in schizophrenia. Psychopharmacol Ser (1989) 0.75
Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis. Eur J Clin Pharmacol (1991) 0.75
3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogs. J Neurosci Res (1975) 0.75
The effects of mianserin therapy on plasma renin activity in depressed patients. Biol Psychiatry (1986) 0.75
Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes. Eur Neurol (1975) 0.75
Determination of HVA and 5-HIAA in ventricular CSF of patients with brain tumors. J Neurosurg Sci (1975) 0.75
Analysis of chlorodesmethyldiazepam and its metabolites in plasma and urine. J Chromatogr (1987) 0.75
Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate. J Clin Endocrinol Metab (1989) 0.75
Molecular forms of cholinesterases in cerebrospinal fluid, blood plasma, and brain tissue of the beagle dog. J Neurosci Res (1979) 0.75
Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes. Acta Diabetol Lat (1986) 0.75
Modification by metaraminol of reserpine action on noradrenaline stores in the rat heart. Eur J Pharmacol (1969) 0.75
[Familial Gaucher's disease in the adult]. Pathologica (1981) 0.75
Inhibition of puerperal lactation by metergoline: interactions with methylergobasine maleate. Gynecol Obstet Invest (1983) 0.75
Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes. Acta Diabetol Lat (1987) 0.75
[An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine]. G Ital Cardiol (1993) 0.75
Stereotyped behavior and hyperthermia in dogs: correlation with the levels of amphetamine and p-hydroxyamphetamine in plasma and CSF. Psychopharmacology (Berl) (1978) 0.75
Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam). Int J Clin Pharmacol Res (1986) 0.75
Determination of sodium flavodate in body fluids by high-performance liquid chromatography: application to clinical pharmacokinetic studies. J Chromatogr (1982) 0.75
Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus. Horm Metab Res (1994) 0.75
Ineffectiveness of ceruletide to reduce food intake and body weight in obese women hospitalized for weight reduction and treated with a restricted diet. A double-blind study. Peptides (1987) 0.75
Insulin requirement in elderly patients with non-insulin dependent diabetes mellitus (NIDDM). Aging (Milano) (1989) 0.75
Paradoxical effect of amphetamine in an endogenous model of the hyperkinetic syndrome in a hybrid dog: correlation with amphetamine and p-hydroxyamphetamine blood levels. Psychopharmacology (Berl) (1979) 0.75
Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and Rh blood groups. Diabete Metab (1988) 0.75
Effect of a cholecystokinin antagonist on some effects of diazepam. Neuropharmacology (1987) 0.75
Homovanillic acid and 5-hydroxyindoleacetic acid modifications in CSF of patients with stroke and multi-infarct dementia. Stroke (1986) 0.75
Determination of dihydroergocristine and dihydroergotamine in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1983) 0.75
Bimodal administration of entacapone in Parkinson's disease patients improves motor control. Eur J Neurol (2008) 0.75
A simple method for detecting overlap of nanogram quantities of choline onto the acetylcholine band in paper electrophoresis. Anal Biochem (1972) 0.75
Determination of sodium 3,4-diaminonaphthalene-1-sulfonate, a Congo Red derivative, in plasma and brain of hamsters by high-performance liquid chromatography after solid-phase extraction and ultraviolet absorbance. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75
Monoamine acid metabolites in ventricular CSF of patients with brain tumours. Acta Neurochir (Wien) (1976) 0.75
Pharmacokinetics and distribution of sodium 3,4-diaminonaphthalene-1-sulfonate, a Congo Red derivative active in inhibiting PrP(res) replication. J Pharm Pharmacol (2004) 0.75